J. Klem

发表

2002 Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Frankfurt, Germany November 19–22, 2002

M. Socinski, V. Jain, C. Belani, 2003 .

Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Frankfurt, Germany November 19–22, 2002

E. Chu, V. Jain, David J. Lee, 2003 .

Highlights from: The 39th Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois; May 31–June 3, 2003

O. Sartor, P. Tyagi, A. D'Orazio, 2003 .

Differentiation of NK1.1 1 , Ly49 1 NK Cells from flt3 1 Multipotent Marrow Progenitor Cells 1

I. Puzanov, N. Williams, Vinay Kumar, 1999 .

B6 Strain Ly49I Inhibitory Gene Expression on T Cells in FVB.Ly49IB6 Transgenic Mice Fails to Prevent Normal T Cell Functions1 2

J. Schatzle, V. Arora, T. George, 2002, The Journal of Immunology.

Highlights from the 39th Annual meeting of the American Society of Clinical Oncology Chicago, Illinois.

P. Tyagi, A. D'Orazio, J. Klem, 2003, Clinical prostate cancer.

Highlights from the 98th annual meeting of the American Urological Association Chicago, IL.

H. Degrendele, Mary Hightower, J. Klem, 2003, Clinical prostate cancer.

Superoxide dismutase and catalase activity in patients with stable angina pectoris.

M. Strzelczyk, J. Kȩdziora, J. Fuchs, 1993, Acta biochimica Polonica.

The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression1

P. Schwartzberg, J. Schatzle, C. Wülfing, 2004, The Journal of Immunology.

Molecule-Associated Protein Expression Signaling Lymphocytic Activation Exhibits Inhibitory Function Independent of The Murine NK Receptor 2B4 (CD244)

P. Schwartzberg, C. Wülfing, Jill M. Mooney, 2004 .

2B4 Is Constitutively Associated with Linker for the Activation of T Cells in Glycolipid-Enriched Microdomains: Properties Required for 2B4 Lytic Function1

J. Schatzle, Vinay Kumar, J. Klem, 2002, The Journal of Immunology.

Required for 2 B 4 Lytic Function Glycolipid-Enriched Microdomains : for the Activation of T Cells in 2 B 4 Is Constitutively Associated with Linker

J. Schatzle, Vinay Kumar, J. Klem, 2002 .

Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice1

J. Schatzle, P. Chaudhary, M. Bennett, 2001, The Journal of Immunology.

Tumor Clearance in Perforin-Deficient Mice Class I-Deficient Stem Cells and Reduces cFLIP Confers Partial Engraftment of MHC Inhibition of the Death Receptor Pathway by

J. Schatzle, P. Chaudhary, Vinay Kumar, 2001 .

Highlights From: 39th Annual Meeting of the American Society of Clinical Oncology;May 31 to June 3, 2003 Chicago, Illinois

V. Jain, A. Gibson, K. Maung, 2003 .

Highlights from the XII European Cancer Conference Copenhagen, Denmark.

N. Price, P. Tyagi, Kesava Reddy, 2003, Clinical prostate cancer.

10th World Conference on Lung Cancer, Vancouver, British Columbia, Canada

S. Ramalingam, C. Belani, David J. Lee, 2003 .

Transgenic Mice Fails to Prevent Normal T Cell Functions

J. Schatzle, V. Arora, Vinay Kumar, 2002 .

5'-nucleotidase and adenosine deaminase activities in blood of patients with unstable angina pectoris.

M. Strzelczyk, J. Klem, S. Puczkowski, 1997, Haematologia.

Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems

I. Puzanov, J. Schatzle, M. Bennett, 1998, Immunological reviews.

2003 Highlights From: 10th World Conference on Lung Cancer Vancouver, British Columbia, Canada August 10-14, 2003

S. Ramalingam, C. Belani, David J. Lee, 2003 .

45th Annual Meeting of the American Society of Hematology December 6-9, 2003.

G. Reddy, N. Price, A. Gibson, 2004, Clinical lymphoma.

Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing

J. Schatzle, C. Wülfing, J. Klem, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Red blood cell adenosine deaminase activity in multiple sclerosis.

M. Strzelczyk, J. Czernicki, J. Klem, 1993, Clinica chimica acta; international journal of clinical chemistry.

Current studies with PTK787, an oral inhibitor of vascular endothelial growth factor in colorectal cancer.

J. Klem, 2003, Clinical colorectal cancer.

Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.

I. Puzanov, N. Williams, V Kumar, 1999, Journal of immunology.

Interface accumulation of receptor/ligand couples in lymphocyte activation: methods, mechanisms, and significance

N. Burroughs, J. Schatzle, C. Wülfing, 2002, Immunological reviews.

Improving Outcomes in Early-Stage Breast Cancer

J. Klem, 2010 .

2007 Highlights from: The 29th Annual San Antonio Breast Cancer Symposium San Antonio, TX, December 2006

D. Tripathy, J. O’Shaughnessy, S. Peck, 2007 .

Multipotent Marrow Progenitor + from flt 3 NK Cells + , Ly 49 + Differentiation of NK 1 . 1

I. Puzanov, N. Williams, Vinay Kumar, 1999 .

Meeting Highlights2007 Highlights from: The 29th Annual San Antonio Breast Cancer Symposium; San Antonio, TX, December 2006

D. Tripathy, J. O’Shaughnessy, S. Peck, 2007 .

Red blood cell superoxide dismutase and catalase activities in patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.

M. Strzelczyk, J. Czernicki, J. Klem, 1996, Polish journal of pharmacology.

Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.

M. Strzelczyk, J. Czernicki, J. Klem, 1995, Polish journal of pharmacology.

2007 Highlights from: The 2007 San Antonio Breast Cancer Symposium San Antonio, TX December 13-16, 2007

J. O’Shaughnessy, T. Abair, S. Peck, 2008 .

Red cell superoxide dismutase and catalase activity in multiple sclerosis.

M. Strzelczyk, J. Czernicki, J. Klem, 1993, Acta biochimica Polonica.

Superoxide dismutase and catalase activity in psoriatic patients treated topically with ointment containing 2-chloroethyl-3-chloropropyl sulfide.

M. Strzelczyk, J. Klem, M. Kopff, 1994, Polish journal of pharmacology.

Gene Expression Profiling to Predict Outcome of Chemotherapy for Early-Stage Breast Cancer

J. O’Shaughnessy, J. Klem, 2003 .

45th Annual Meeting of the American Society of Hematology December 6-9, 2003.

A. Gibson, J. Klem, Nancy Price, 2004 .

2003 Highlights From: 10th World Conference on Lung Cancer Vancouver, British Columbia, Canada August 10-14, 2003

S. Ramalingam, C. Belani, David J. Lee, 2003, Clinical Lung Cancer.